Literature DB >> 2675130

Methyltransferase pharmacogenetics.

R Weinshilboum1.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2675130     DOI： 10.1016/0163-7258(89)90048-x

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN： 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  16 in total

Review 1.  Polymerase chain reaction and its potential as a pharmacokinetic tool.

Authors:  M H Heim
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

Review 2.  Inborn 'errors' of drug metabolism. Pharmacokinetic and clinical implications.

Authors:  M S Lennard; G T Tucker; H F Woods
Journal:  Clin Pharmacokinet       Date:  1990-10       Impact factor: 6.447

3.  Modulation of cytosine arabinoside-induced proliferation inhibition by exogenous adenosylmethionine.

Authors:  E Rakasz; J Sugar; O Csuka
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 4.  Molecular basis of polymorphic drug metabolism.

Authors:  A K Daly
Journal:  J Mol Med (Berl)       Date:  1995-11       Impact factor: 4.599

Review 5.  Human pharmacogenomic variations and their implications for antifungal efficacy.

Authors:  Joseph Meletiadis; Stephen Chanock; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

6.  Human thiopurine methyltransferase pharmacogenetics. Kindred with a terminal exon splice junction mutation that results in loss of activity.

Authors:  D M Otterness; C L Szumlanski; T C Wood; R M Weinshilboum
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

Review 7.  Genetically determined adverse drug reactions involving metabolism.

Authors:  M S Lennard
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

Review 8.  Pharmacogenetic phenotyping and genotyping. Present status and future potential.

Authors:  F J Gonzalez; J R Idle
Journal:  Clin Pharmacokinet       Date:  1994-01       Impact factor: 6.447

9.  Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine.

Authors:  C L Szumlanski; R M Weinshilboum
Journal:  Br J Clin Pharmacol       Date:  1995-04       Impact factor: 4.335

10.  Mouse kidney histamine N-methyltransferase: assay conditions, biochemical properties and strain variation.

Authors:  M C Scott; R Guerciolini; C Szumlanski; R M Weinshilboum
Journal:  Agents Actions       Date:  1991-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.